ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 91 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $468,000 | +5.6% | 312,059 | 0.0% | 0.00% | – |
Q4 2017 | $443,000 | -38.0% | 312,059 | 0.0% | 0.00% | – |
Q3 2017 | $714,000 | +68.4% | 312,059 | -0.7% | 0.00% | – |
Q2 2017 | $424,000 | -36.9% | 314,224 | 0.0% | 0.00% | – |
Q1 2017 | $672,000 | -51.5% | 314,224 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $1,386,000 | -7.0% | 314,224 | +2.3% | 0.00% | 0.0% |
Q3 2016 | $1,490,000 | +48.4% | 307,210 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $1,004,000 | -38.4% | 304,149 | -33.7% | 0.00% | 0.0% |
Q1 2016 | $1,629,000 | – | 458,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
NWAM LLC | 20,000 | $30,000 | 0.01% |